# Juror 05 — independent final vote

**65/100, unchanged.** Verdict: advance as a credible research/education demonstrator; no demonstrated operational adoption, quantum advantage, or basis to declare it the overall winner. Confidence is higher in demo execution after cross-examination, but operational value and audience fit remain unresolved.

| Dimension | Points / maximum |
|---|---:|
| Problem | 6 / 7 |
| User | 5 / 8 |
| Domain | 5 / 8 |
| UX | 4 / 6 |
| Architecture | 5 / 6 |
| Tests | 6 / 9 |
| Data | 5 / 8 |
| Classical | 8 / 10 |
| Quantum correctness | 7 / 10 |
| Quantum contribution | 3 / 8 |
| Experiments | 4 / 7 |
| Performance | 2 / 4 |
| Security | 3 / 4 |
| Adoption | 1 / 3 |
| Pitch | 1 / 2 |

Array in shared order: `[6,5,5,4,5,6,5,8,7,3,4,2,3,1,1]` = 65.

## Actual challenge, resolution, and revised confidence

After initial ballots were collected, read the cross-examination docket, J7 initial, J12 final, and chair-demo-summary.json. **Challenge to J7's full 2/2 pitch credit:** all sixteen routes rendering and a successful simulated donor acceptance establish a working demo, but do they make the pitch fully coherent when the default MILP leaves 27/38 units unmet versus greedy's 2, and README overstates ABO/Rh and universal latency? Sent this specific question to J7. My resolution is to accept the reported live functionality and withhold the last pitch point: operational interpretation matters as much as the ability to render the demonstration. J7 also explicitly withholds adoption/quantum-advantage claims, so the disagreement is scoring of pitch completeness, not whether the interface exists.

**J12's distinction resolves the mathematical issue but sharpens the product issue.** Independently reread `optimization/objective.py:227–245` and `optimization/milp.py:115–124`: unmet demand carries a finite weighted penalty rather than an absolute service requirement. J12 reports a newly executed critical-demand counterexample where shortage costs 15 versus shipping 112. I did not rerun that case. The resulting shortage is consistent with the model, not evidence of an incorrect solver. The missing product decision is who approves that policy and how clearly a user understands that “optimal” may mean leaving serviceable requests unfilled. `frontend/src/pages/Optimization.jsx:587–597` still contains the hard-coded seven-node/222-bit explanation; I checked this source directly after the challenge.

**Chair execution is useful positive evidence, explicitly not my execution.** The supplied twelve-run summary covers three named scenarios × greedy/MILP/exact/QAOA, all PASS, with equal objectives within each case (25.2, 215.6, 140). This strengthens confidence that the controlled demo can actually run. The three QAOA records have optimizer_success=false while returning feasible candidates; their feasible-shot rates are .3125, .1171875, and .5234375. That distinction should survive into presentation language: a usable sample is not optimizer convergence, repeatability across seeds, or advantage. HTTP QAOA times approximately .18–.32 seconds are suitable for this bounded demo, not evidence of regional emergency-scale performance.

## Why no score change

My initial score already credited an implemented API/solver/demo pipeline and penalized unproved user adoption, scope divergence, and incremental quantum value. Live successes now strengthen that credit without supplying user research, integrations, repeated institutional usage, or quantum benefit. The docket reports substantially broader tests and experiments than I independently inspected; I accept them as corroborating evidence without relabeling their executions as mine or converting a bounded product review into a full mathematical/security certification. No consensus target influenced this vote.

The strongest evidence-supported distinction remains **transparent comparative research with inspectable limitations**. A winning-product claim needs an identified repeat user and measured benefit against an appropriate classical baseline. The breadth of pages, a simulated emergency workflow, and an authentic QAOA circuit are substantial engineering accomplishments, but do not themselves answer that question.

## Final recommendation and uncertainty

Lead with a researcher workflow: inspect synthetic inputs, apply a disruption, compare feasible allocations and unmet demand under explicit weights, then explain what quantum added or failed to add. Keep donor coordination a clearly separate simulated extension. Suggested pitch: “BloodFlow-Q is a synthetic logistics research workspace that compares classical allocation with simulated QAOA and makes feasibility, shortage, and method limitations inspectable.”

Remaining uncertainty: actual operator comprehension, accessibility across devices, repeatable QAOA behavior outside supplied cases, private database enforcement in deployment, and validated institutional demand. My own live observations remain the initial health/catalog GETs only; no new browser test, solver execution, real outreach, or application mutation was performed in this final phase. Initial report remains unchanged.
